Aoxiang Pharmaceutical announced that its wholly-owned subsidiary Zhejiang Qizheng Pharmaceutical Co., Ltd. recently received the “Drug Registration Certificate” for rucotinib phosphate tablets approved and issued by the State Drug Administration. The specifications are 5 mg, 15 mg, and 20 mg. The drug approval numbers are Sinopharm H20265640, Sinopharm standard H20265641, and Sinopharm standard H20265642. This certification is considered to have passed the generic drug consistency evaluation.

Aoxiang Pharmaceutical announced that its wholly-owned subsidiary Zhejiang Qizheng Pharmaceutical Co., Ltd. recently received the “Drug Registration Certificate” for rucotinib phosphate tablets approved and issued by the State Drug Administration. The specifications are 5 mg, 15 mg, and 20 mg. The drug approval numbers are Sinopharm H20265640, Sinopharm standard H20265641, and Sinopharm standard H20265642. This certification is considered to have passed the generic drug consistency evaluation.